Sign in or Register   Sign in or Register
  |  

Mouse Anti-ICOSLG Recombinant Antibody (CBYY-1989) (CBMAB-2338-YY)

This product is mouse antibody that recognizes ICOSLG. The antibody CBYY-1989 can be used for immunoassay techniques such as: FC, IHC-P
See all ICOSLG antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYY-1989
Antibody Isotype
IgG2b, κ
Application
FC, IHC-P

Basic Information

Immunogen
Human B7H2-mIg fusion protein
Specificity
Human
Antibody Isotype
IgG2b, κ
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Concentration
0.5 mg/mL
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Inducible T Cell Costimulator Ligand
Introduction
ICOSLG (Inducible T Cell Costimulator Ligand) is a Protein Coding gene. Diseases associated with ICOSLG include Inclusion Body Myositis and Immunodeficiency With Hyper-Igm, Type 2.Among its related pathways are Allograft rejection and Innate Immune System.
Entrez Gene ID
23308
UniProt ID
O75144
Alternative Names
Inducible T Cell Costimulator Ligand
Function
Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulatory signal for T-cell proliferation and cytokine secretion; induces also B-cell proliferation and differentiation into plasma cells. Could play an important role in mediating local tissue responses to inflammatory conditions, as well as in modulating the secondary immune response by co-stimulating memory T-cell function (By similarity).
Biological Process
Adaptive immune response Source: UniProtKB-KW
B cell activation Source: UniProtKB-KW
Defense response Source: UniProtKB
Hyperosmotic response Source: UniProtKB
Positive regulation of activated T cell proliferation Source: UniProtKB
Regulation of cytokine production Source: GO_Central
Signal transduction Source: UniProtKB
T cell activation Source: UniProtKB
T cell receptor signaling pathway Source: GO_Central
Cellular Location
Cell membrane
Topology
Extracellular: 19-256
Helical: 257-277
Cytoplasmic: 278-302

Zhang, Y., Wang, X. L., Liu, J. J., Qian, Z. Y., Pan, Z. Y., Song, N. P., ... & Zhang, X. (2023). ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous-Carcinoma Immune Microenvironment. Journal of Inflammation Research, 977-992.

Külp, M., Siemund, A. L., Larghero, P., Dietz, A., Alten, J., Cario, G., ... & Marschalek, R. (2022). The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t (4; 11) acute lymphoblastic leukemia. Iscience, 25(7).

Zhang, C., Wang, F., Sun, N., Zhang, Z., Zhang, G., Zhang, Z., ... & He, J. (2022). The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma. Genes & diseases, 9(2), 415-428.

Külp, M., Larghero, P., Dietz, A., Cario, G., Eckert, C., Caye-Eude, A., ... & Marschalek, R. (2022). The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t (4; 11) ALL. Klinische Pädiatrie, 234(03), 174-175.

Roussel, L., & Vinh, D. C. (2021). ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency. Current Opinion in Immunology, 72, 21-26.

Holst, C. B., Christensen, I. J., Vitting-Seerup, K., Skjøth-Rasmussen, J., Hamerlik, P., Poulsen, H. S., & Johansen, J. S. (2021). Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma. Neuro-Oncology Advances, 3(1), vdab072.

Külp, M., Siemund, A. L., Meyer, C., Larghero, P., Dietz, A., Alten, J., ... & Marschalek, R. (2021). Implication of ICOSLG on Relapse in Infant T (4; 11) Acute Lymphoblastic Leukemia. Blood, 138(Supplement 1), 3481-3481.

Iwata, R., Hyoung Lee, J., Hayashi, M., Dianzani, U., Ofune, K., Maruyama, M., ... & Asai, A. (2020). ICOSLG-mediated regulatory T-cell expansion and IL-10 production promote progression of glioblastoma. Neuro-oncology, 22(3), 333-344.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-ICOSLG Recombinant Antibody (CBYY-1989)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare